APA (7th ed.) Citation

Zhao, J., & Pietrantonio, F. (2026). Long-term survival outcomes with immune checkpoint inhibition in PD-L1 low or intermediate expressing gastroesophageal adenocarcinoma. Annals of Oncology, 37(6), 754. https://doi.org/10.1016/j.annonc.2026.02.016

Chicago Style (17th ed.) Citation

Zhao, J.J, and F. Pietrantonio. "Long-term Survival Outcomes with Immune Checkpoint Inhibition in PD-L1 Low or Intermediate Expressing Gastroesophageal Adenocarcinoma." Annals of Oncology 37, no. 6 (2026): 754. https://doi.org/10.1016/j.annonc.2026.02.016.

MLA (9th ed.) Citation

Zhao, J.J, and F. Pietrantonio. "Long-term Survival Outcomes with Immune Checkpoint Inhibition in PD-L1 Low or Intermediate Expressing Gastroesophageal Adenocarcinoma." Annals of Oncology, vol. 37, no. 6, 2026, p. 754, https://doi.org/10.1016/j.annonc.2026.02.016.